English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/74863
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

DC FieldValueLanguage
dc.contributor.authorAli, Nahid-
dc.contributor.authorMekuria, Asrat Hailu-
dc.contributor.authorRequena, José María-
dc.contributor.authorEngwerda, Christian-
dc.date.accessioned2013-04-22T17:57:34Z-
dc.date.available2013-04-22T17:57:34Z-
dc.date.issued2012-
dc.identifier.citationJournal of Tropical Medicine 2012: 780809 (2012)es_ES
dc.identifier.issn1687-9686-
dc.identifier.urihttp://hdl.handle.net/10261/74863-
dc.description.abstractLeishmaniasis is a major vector-borne parasitic disease affecting 12 million people worldwide. With a broad range of clinical manifestations, ranging from self-healing skin ulcers to disfiguring mucosal lesions to life-threatening infections of visceral organs (liver and spleen), the disease has become a serious human health issue, particularly in developing countries. Among all of its forms, visceral leishmaniasis (VL, also known as kala-azar), caused by the Leishmania donovani complex (i.e., L. donovani and L. infantum in Old World and L. chagasi in New World), is often fatal in the absence of treatment. Although humans are the principal hosts for L. donovani, canine species are the main reservoirs of L. infantum. Canine VL affects millions of dogs and is associated with outbreaks of human VL and hence has become a major public health issue. The lack of vaccines to prevent and/or treat these infections, as well as the emergence of drug resistant parasites, is serious impediments to control leishmaniasis. Therefore, developing new prophylactic and therapeutic strategies against this disease is urgently required. However, for this to occur, a better understanding of the complex immune mechanisms generated in response to infection and defining those involved in resistance to infection is required. In this special issue on “Immunity to visceral leishmaniasis”, several selected papers will discuss these issues.-
dc.language.isoenges_ES
dc.publisherHindawi Publishing Corporationes_ES
dc.rightsopenAccesses_ES
dc.subjectLeishmaniasises_ES
dc.subjectDiseasees_ES
dc.subjectKala-azares_ES
dc.subjectCanine specieses_ES
dc.titleImmunity to Visceral Leishmaniasises_ES
dc.typeartículoes_ES
dc.identifier.doi10.1155/2012/780809-
dc.description.peerreviewedPeer reviewedes_ES
dc.relation.publisherversionhttp://dx.doi.org/10.1155/2012/780809es_ES
Appears in Collections:(CBM) Artículos
Files in This Item:
File Description SizeFormat 
RequenaJM_JTropMed_780809.pdf416,81 kBAdobe PDFThumbnail
View/Open
Show simple item record
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.